Cargando…
Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
Intraperitoneal (IP) chemotherapy is an effective way of treating peritoneal carcinomatosis of colorectal origin after complete cytoreduction. Although IP therapy has been already performed for many years, no standardized treatment design has been developed in terms of schedule, residence time, drug...
Autores principales: | De Smet, L., Ceelen, W., Remon, J. P., Vervaet, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621299/ https://www.ncbi.nlm.nih.gov/pubmed/23589707 http://dx.doi.org/10.1155/2013/720858 |
Ejemplares similares
-
Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling
por: Rahimi-Gorji, Mohammad, et al.
Publicado: (2022) -
Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
por: Van de Sande, Leen, et al.
Publicado: (2019) -
Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule
por: Steuperaert, Margo, et al.
Publicado: (2017) -
Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome
por: Verstraelen, Hans, et al.
Publicado: (2016) -
Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
por: Xie, Duoli, et al.
Publicado: (2022)